These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4804278)

  • 1. The role of circulating antigen as an inhibitor of tumour immunity in man.
    Currie G
    Br J Cancer Suppl; 1973 Aug; 1():153-61. PubMed ID: 4804278
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific antibody activation of lymphocytes for cell-mediated cytotoxicity against cultured target cells.
    Takasugi M; Kinoshita K
    J Natl Cancer Inst; 1974 Dec; 53(6):1539-44. PubMed ID: 4474407
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of active immunization with irradiated tumour cells on specific serum inhibitors of cell-mediated immunity in patients with disseminated cancer.
    Currie GA
    Br J Cancer; 1973 Jul; 28(1):25-35. PubMed ID: 4724610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of immunity in cancer.
    Baldwin RW
    Pathobiol Annu; 1981; 11():155-75. PubMed ID: 6460216
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Tumour immunity - cellular and humoral responses during tumour growth.
    Baldwin RW; Embleton MJ; Price MR; Robins RA
    Br J Radiol; 1975 May; 48(569):413. PubMed ID: 1139105
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen.
    Currie GA; Basham C
    Br J Cancer; 1972 Dec; 26(6):427-38. PubMed ID: 4119105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of circulating antibody in the control of metastases.
    Lewis MG
    J Clin Pathol Suppl (R Coll Pathol); 1974; 7():83-93. PubMed ID: 4598354
    [No Abstract]   [Full Text] [Related]  

  • 8. Significance of tumour associated antigens on human colonic carcinomata.
    Embleton MJ
    Br J Cancer Suppl; 1973 Aug; 1():142-52. PubMed ID: 4804277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: What is the clinical relevance of in-vitro tumour immunity test?
    Moore M
    Br J Radiol; 1975 May; 48(569):413. PubMed ID: 1139106
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the inhibitory effects of lymphocytes from patients with and without cancer on the growth of human tumour cells in culture.
    Jamieson CW
    Br J Surg; 1972 Apr; 59(4):302. PubMed ID: 5020745
    [No Abstract]   [Full Text] [Related]  

  • 11. Some recent developments in human tumour immunology.
    The TH
    Folia Med Neerl; 1972; 15(6):279-90. PubMed ID: 4565658
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological studies in melanoma patients treated with BCG.
    De Vries JE; Rümke P
    Br J Cancer Suppl; 1973 Aug; 1():97-102. PubMed ID: 4804294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cellular immunity to tumor antigens].
    Hellström KE; Hellström I
    Lakartidningen; 1974 Feb; 71(6):473-8. PubMed ID: 4837237
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunological studies with human neoplasms.
    Morton DL
    J Reticuloendothel Soc; 1971 Jul; 10(1):137-60. PubMed ID: 4941264
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigen-reactive cells to tumor antigens in normal and tumor patients.
    Falk RE; MacGregor AB
    J Surg Res; 1976 Mar; 20(3):247-53. PubMed ID: 772313
    [No Abstract]   [Full Text] [Related]  

  • 16. Cellular immunity and blocking antibodies to tumors.
    Hellström I; Hellström KE
    J Reticuloendothel Soc; 1971 Jul; 10(1):131-6. PubMed ID: 5121177
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhancement of cell-mediated immunity in melanoma patients immunized with murine anti-idiotypic monoclonal antibodies (MELIMMUNE) that mimic the high molecular weight proteoglycan antigen.
    Pride MW; Shuey S; Grillo-Lopez A; Braslawsky G; Ross M; Legha SS; Eton O; Buzaid A; Ioannides C; Murray JL
    Clin Cancer Res; 1998 Oct; 4(10):2363-70. PubMed ID: 9796966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies to two determinants of melanoma-antigen p97 act synergistically in complement-dependent cytotoxicity.
    Hellström I; Brown JP; Hellström KE
    J Immunol; 1981 Jul; 127(1):157-60. PubMed ID: 6787119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytotoxic immunity indices of melanoma B16 growth in mice].
    Korosteleva TA; Veresova OV
    Vopr Onkol; 1980; 26(1):67-70. PubMed ID: 7355591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction and inhibition of host immunity to experimental neoplasms. Discussion.
    Br J Cancer Suppl; 1973 Aug; 1():62-71. PubMed ID: 4804291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.